- Home
- HTT vs AMRN Comparison
HTT vs AMRN Comparison
Compare HTT & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HTT
High Templar Tech Limited American depositary shares each representing one Class A ordinary share
Current Price
Company Overview
Basic Information| Metric | HTT | AMRN |
|---|---|---|
| Founded | 2014 | 1989 |
| Country | China | Ireland |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 352.5M | 287.9M |
| IPO Year | 2017 | 1998 |
Fundamental Metrics
Financial Performance| Metric | HTT | AMRN |
|---|---|---|
| Price | $2.06 | $11.56 |
| Analyst Decision | | Strong Sell |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $12.50 |
| AVG Volume (30 Days) | ★ 74.5K | 62.0K |
| Earning Date | 10-14-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $181,104,000.00 |
| Revenue This Year | $92,865.41 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.14 | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $1.88 | $11.25 |
| 52 Week High | $3.99 | $20.90 |
Technical Indicators
Market Signals| Indicator | HTT | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 24.07 | 25.75 |
| Support Level | $1.88 | N/A |
| Resistance Level | $2.69 | $15.34 |
| Average True Range (ATR) | 0.07 | 0.35 |
| MACD | -0.02 | -0.06 |
| Stochastic Oscillator | 13.07 | 13.13 |
Price Performance
Historical ComparisonAbout HTT High Templar Tech Limited American depositary shares each representing one Class A ordinary share
High Templar Tech Ltd is an enabler of financial technology. High Templar is focusing on exploring business opportunities globally to satisfy clients' demand by leveraging its technology know-how and financial service capabilities. The company focus empowering financial institutions with its technological capabilities, helping them improve marketing and operational efficiency and efficiently connect their diverse financial products with online traffic.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.